Literature DB >> 9247501

Endothelial dysfunction: does it matter? Is it reversible?

D S Celermajer1.   

Abstract

Until recently, the endothelium was regarded as a relatively inert cell layer. However, over the past 20 years, research has revealed an extraordinary array of endothelial functions, including control over coagulation, fibrinolysis, arterial tone and vascular growth. Importantly, endothelial dysfunction has been implicated as a key event in the pathogenesis of atherosclerosis, coronary vasoconstriction and, probably, myocardial ischemia. The recent demonstration that endothelial dysfunction may be reversible raises the possibility of slowing the progression of atherosclerosis or modifying arterial function, or both, to decrease the risk of acute cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247501     DOI: 10.1016/s0735-1097(97)00189-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  90 in total

Review 1.  [Plaque stabilization and endothelial protection by cholesterol synthesis inhibitors].

Authors:  D Müller-Wieland; M Faust; J Kotzka; W Krone
Journal:  Herz       Date:  1999-05       Impact factor: 1.443

Review 2.  Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.

Authors:  R A Archbold; A D Timmis
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

3.  Endothelial dysfunction in the smokers can be improved with oral cilostazol treatment.

Authors:  Kyu Seop Kim; Hyung Seo Park; Il Soon Jung; Jae-Hyeong Park; Kye Taek Ahn; Seon-Ah Jin; Yong Kyu Park; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  J Cardiovasc Ultrasound       Date:  2011-03-31

Review 4.  Assessing endothelial function as a risk factor for cardiovascular disease.

Authors:  Alan L Hinderliter; Melissa Caughey
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

5.  Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction.

Authors:  D Yinon; L Lowenstein; S Suraya; R Beloosesky; O Zmora; A Malhotra; G Pillar
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

6.  An improved method to measure nitrate/nitrite with an NO-selective electrochemical sensor.

Authors:  Yong Chool Boo; Sarah L Tressel; Hanjoong Jo
Journal:  Nitric Oxide       Date:  2006-09-15       Impact factor: 4.427

Review 7.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Assessment of vasoreactivity using videodensitometry coronary angiography.

Authors:  Sabee Molloi; Gholam R Berenji; Trien T Dang; Ghassan Kassab
Journal:  Int J Cardiovasc Imaging       Date:  2003-08       Impact factor: 2.357

9.  Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trial.

Authors:  H J Mulder; M J Schalij; B Kauer; R F Visser; P R van Dijkman; J W Jukema; A H Zwinderman; A V Bruschke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

Review 10.  The L-arginine-nitric oxide pathway in hypertension.

Authors:  Malte Kelm
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.